Uniquely understanding industry needs from a business perspective

25/06/18

The IDC Marketscape report notes, customers give PwC “high marks for underpromising and overdelivering”

Speaking to PwC’s history in the space, the IDC Marketscape report notes, “PwC is among the main service providers of R&D strategic consulting and carries a legacy of strong strategic consulting services to the industry. The company has a broad customer base, a strong global footprint, and significant success in engaging and expanding its relationship with top-tier pharmaceutical companies.” The report continues, “PwC has extensive experience working with life science companies across all three sections of the industry: pharmaceutical, biotech, and medical devices.”

On PwC’s current standing in the industry, the IDC Marketscape report states, “More than 70% of PwC's life science customers are large corporations with revenue over $1 billion, with a significant base of customers spread across North America, Europe, and Asia/Pacific.”

IDC Marketscape expands on client feedback on PwC’s services, “Relative to other vendors discussed in this report and based on feedback from multiple customer references, PwC continues to receive high marks for underpromising and overdelivering; bringing deep, industry-specific knowledge to engagements; and uniquely understanding industry needs from a business perspective.” 

Kelly Barnes, Global & US Health Industries Leader at PwC, said of the leadership position, “We are delighted to be named a leader for our work in Worldwide Life Science R&D Strategic Consulting. We bring industry based R&D experience and a deep understanding of cross-organisational operations to support clients in optimising strategy, management and lowering costs so they can achieve increased performance by improving the efficiency and effectiveness of their R&D operations.”

"We help our clients meet the constantly evolving and increasingly demanding challenges present in the healthcare industry. We work closely with our clients to help formulate a new strategy for success.”

Anup Kharode, Pharmaceutical and Life Sciences R&D Practice Leader at PwC US

IDC MarketScape vendor analysis model is designed to provide an overview of the competitive fitness of ICT suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. The Capabilities score measures vendor product, go-to-market and business execution in the shortterm. The Strategy score measures alignment of vendor strategies with customer requirements in a 3-5-year timeframe. Vendor market share is represented by the size of the circles. Vendor year-over-year growth rate relative to the given market is indicated by a plus, neutral or minus next to the vendor name.

  • To find out more about how PwC has been evaluated by leading business, technology and industry analysts visit PwC Analyst Views
  • At PwC, our purpose is to build trust in society and solve important problems. We’re a network of firms in 158 countries with more than 236,000 people who are committed to delivering quality in assurance, advisory and tax services. Find out more and tell us what matters to you by visiting us at www.pwc.com

Contact us

Rob Donnelly

Global Analyst & Advisor Relations Leader, PwC United States

Tel: +1 (917) 471 3355

Follow us